San Mateo, CA
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from todayβs most challenging diseases.
bighatbio.comThese are collections BigHat Biosciences is a part of. Click on the collection name to view similar companies.
Series B
$75,000,000
Series A
$19,000,000
Seed
$5,302,511
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on BigHat Biosciences.